(Q43061595)

13 November 2017

Lymphocyte proteomics of Parkinson's disease patients reveals cytoskeletal protein dysregulation and oxidative stress (English)

1 reference

13 November 2017

0 references

1 reference

8

1 reference

13 November 2017

7

Leonardo Lopiano

1 reference

13 November 2017

5

Maurizio Zibetti

1 reference

13 November 2017

Silvia Mila

1

1 reference

13 November 2017

Alessandra Giuliano Albo

2

1 reference

13 November 2017

Davide Corpillo

3

1 reference

13 November 2017

Sabrina Giraudo

4

1 reference

13 November 2017

Enrico M Bucci

6

1 reference

13 November 2017

1 April 2009

1 reference

13 November 2017

Biomarkers in Medicine

1 reference

13 November 2017

3

1 reference

13 November 2017

2

1 reference

13 November 2017

117-128

1 reference

13 November 2017

Pathways to Parkinsonism

1 reference

Molecular pathogenesis of Parkinson disease

21 January 2018

1 reference

Understanding the molecular causes of Parkinson's disease.

21 January 2018

1 reference

The pathogenesis of cell death in Parkinson's disease--2007.

21 January 2018

1 reference

Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease

21 January 2018

1 reference

Biomedicine. Parkinson's--divergent causes, convergent mechanisms.

21 January 2018

1 reference

Ubiquitin-proteasome system and Parkinson's diseases

21 January 2018

1 reference

Pathogenesis of nigral cell death in Parkinson's disease

21 January 2018

1 reference

Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system

21 January 2018

1 reference

Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease

21 January 2018

1 reference

Update on the genetics of Parkinson's disease

21 January 2018

1 reference

Familial aggregation of Parkinson disease: a comparative study of early-onset and late-onset disease

21 January 2018

1 reference

Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein

21 January 2018

1 reference

Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?

21 January 2018

1 reference

Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: a case for the selective vulnerability of the substantia nigra

21 January 2018

1 reference

Modifications of the iron-neuromelanin system in Parkinson's disease

21 January 2018

1 reference

Alpha-synuclein and Parkinson's disease: a proteomic view

21 January 2018

1 reference

Does Parkinson's disease have an immunological basis? The evidence and its therapeutic implications

21 January 2018

1 reference

Inflammation and neurodegeneration in Parkinson's disease

21 January 2018

1 reference

Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA.

21 January 2018

1 reference

Oxidative damage and cytogenetic analysis in leukocytes of Parkinson's disease patients.

21 January 2018

1 reference

Peripheral markers of apoptosis in Parkinson's disease: the effect of dopaminergic drugs

21 January 2018

1 reference

Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease

21 January 2018

1 reference

Autosomal recessive juvenile parkinsonism Cys212Tyr mutation in parkin renders lymphocytes susceptible to dopamine- and iron-mediated apoptosis.

21 January 2018

1 reference

Caveolae compartmentalization of heme oxygenase-1 in endothelial cells

21 January 2018

1 reference

Oxidative-stress-induced apoptosis in PBLs of two patients with Parkinson disease secondary to alpha-synuclein mutation.

21 January 2018

1 reference

The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease

21 January 2018

1 reference

Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegeneration.

21 January 2018

1 reference

Proteome analysis of human substantia nigra in Parkinson's disease.

21 January 2018

1 reference

Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases

21 January 2018

1 reference

Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: relevance to Parkinson disease.

21 January 2018

1 reference

Proteomics in neurodegeneration--disease driven approaches.

21 January 2018

1 reference

2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases

21 January 2018

1 reference

The proteomic approach in Parkinson's disease

21 January 2018

1 reference

Identification of novel proteins associated with both alpha-synuclein and DJ-1

21 January 2018

1 reference

Protein expression in a Drosophila model of Parkinson's disease

21 January 2018

1 reference

Lifetime proteomic profiling of an A30P alpha-synuclein Drosophila model of Parkinson's disease.

21 January 2018

1 reference

Proteomics of Caenorhabditis elegans over-expressing human alpha-synuclein analyzed by fluorogenic derivatization-liquid chromatography/tandem mass spectrometry: identification of actin and several ribosomal proteins as negative markers at early Par

21 January 2018

1 reference

Quantitative proteomics of a presymptomatic A53T alpha-synuclein Drosophila model of Parkinson disease

21 January 2018

1 reference

Proteomics of human neurodegenerative diseases

21 January 2018

1 reference

Biomarkers and Parkinson's disease

21 January 2018

1 reference

Biomarkers in Parkinson's disease

21 January 2018

1 reference

Proteomic analysis of peripheral T lymphocytes, suitable circulating biosensors of strictly related diseases

21 January 2018

1 reference

Proteomic analysis of peripheral T-lymphocytes in patients with asthma.

21 January 2018

1 reference

Sequential solubilization of proteins precipitated with trichloroacetic acid in acetone from cultured Catharanthus roseus cells yields 52% more spots after two-dimensional electrophoresis

21 January 2018

1 reference

Tropomyosin isoforms: divining rods for actin cytoskeleton function

21 January 2018

1 reference

Tropomyosin-based regulation of the actin cytoskeleton in time and space

21 January 2018

1 reference

The actin cytoskeleton: a key regulator of apoptosis and ageing?

21 January 2018

1 reference

Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin A

21 January 2018

1 reference

Cofilin expression induces cofilin-actin rod formation and disrupts synaptic structure and function in Aplysia synapses.

21 January 2018

1 reference

Changes in cytoskeletal gene expression linked to MPTP-treatment in Mice

21 January 2018

1 reference

Parkin interacts with LIM Kinase 1 and reduces its cofilin-phosphorylation activity via ubiquitination

21 January 2018

1 reference

Differential expression of the parkin gene in the human brain and peripheral leukocytes

21 January 2018

1 reference

Differential expression of splice variant and wild-type parkin in sporadic Parkinson's disease.

21 January 2018

1 reference

Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells

21 January 2018

1 reference

Protein expression overlap: more important than which proteins change in expression?

21 January 2018

1 reference

Protein disulfide isomerase in Alzheimer disease.

21 January 2018

1 reference

Proteomic shifts in embryonic stem cells with gene dose modifications suggest the presence of balancer proteins in protein regulatory networks

21 January 2018

1 reference

Déjà vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins.

21 January 2018

1 reference

Recognition of fibrinogen by leukocyte integrins

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/BMM.09.4

1 reference

13 November 2017

1 reference